Objectives:This research investigates level of empowerment, decisional skills, and the perceived relationship with the clinician, of women in childbirth age, also in relationship with clinical variables such as epilepsy type, seizure frequency, therapy, and pregnancy status. In particular, as concerning therapy, we were interested in women who take Valproic Acid (VPA), for its specific balance of risks and benefits, especially in pregnant women.
Methods:The sample is composed of 60 women with epilepsy (6 were excluded), who underwent a standardised clinical protocol for assessment of level of empowerment, decisional skills and of their judgment about how they feel to be involved by their clinician in medical decision making.
Results:Overall, the sample does not show signs of low empowerment level nor of abnormal decision-making patterns.The type of epilepsy, the frequency of seizures and the treatment type (VPA versus no VPA) do not impact on empowerment, nor on decision styles nor on medical relationship, with the only exception of a specific decision style, the avoidant style, that is more frequent in women treated with VPA with respect to those taking other therapies.Interestingly, regarding VPA dosage, we found that patients taking equal or more than 700 mg/day of VPA have lower scores on empowerment in all dimensions compared to women with a VPA dosage lower than 700 mg/day.
Conclusions: Shared decision-making including improved decision quality, more informed choices and better treatment concordance, should be a central part of epilepsy care. In addition, for clinicians it would be useful to have specific tools to know if the patient has really understood the risks and benefits of AEDs, particularly VPA, and all treatment alternatives. Turner et al. 3